Fresnillo (LON:FRES) reported what management described as record financial performance for 2025, supported by higher precious metals prices, continued cost control, and stable operating results. Chie ...
Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results